{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:33:20Z","timestamp":1769632400029,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s40291-023-00666-x","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T06:02:16Z","timestamp":1691388136000},"page":"621-630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic Characterization of a Cohort of Italian Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3472-8898","authenticated-orcid":false,"given":"Paola","family":"Concolino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Perrucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Carrozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Urbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"key":"666_CR1","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"Speiser PW, Ng P, Sinaii N, Leschek EW, Green-Golan L, VanRyzin C, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:4043\u201388.","journal-title":"J Clin Endocrinol Metab"},{"key":"666_CR2","first-page":"31431","volume":"17","author":"D El-Maouche","year":"2017","unstructured":"El-Maouche D, Arlt W, Merke DP. Congenital adrenal hyperplasia. Lancet. 2017;17:31431\u20139.","journal-title":"Lancet"},{"key":"666_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","volume":"41","author":"H Falhammar","year":"2012","unstructured":"Falhammar H, Thor\u00e9n M. Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine. 2012;41:355\u201373.","journal-title":"Endocrine"},{"key":"666_CR4","first-page":"bnab016","volume":"7","author":"HL Claahsen-van der Grinten","year":"2021","unstructured":"Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H, et al. Congenital adrenal hyperplasia\u2014current insights in pathophysiology, diagnostics and management. Endocr Rev. 2021;7:bnab016.","journal-title":"Endocr Rev"},{"key":"666_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1687-9856-2010-625105","volume":"2010","author":"SF Witchel","year":"2010","unstructured":"Witchel SF, Azziz R. Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol. 2010;2010: 625105.","journal-title":"Int J Pediatr Endocrinol"},{"key":"666_CR6","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.4103\/2230-8210.145077","volume":"18","author":"V Neocleous","year":"2014","unstructured":"Neocleous V, Shammas C, Phedonos AA, Phylactou LA, Skordis N. Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations. Indian J Endocrinol Metab. 2014;18:S72\u20139.","journal-title":"Indian J Endocrinol Metab."},{"key":"666_CR7","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/gim.2017.46","volume":"19","author":"F Hannah-Shmouni","year":"2017","unstructured":"Hannah-Shmouni F, Morissette R, Sinaii N, Elman M, Prezant TR, Chen W, Pulver A, Merke DP. Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians. Genet Med. 2017;19:1276\u20139.","journal-title":"Genet Med"},{"key":"666_CR8","first-page":"447","volume":"3","author":"S Israel","year":"2006","unstructured":"Israel S, Weinrib L, Weintrob N, Miller K, Brautbar C. Distribution of the V281L mutation of the CYP21 gene in Israeli congenital adrenal hyperplasia patients and its association with HLA- B14. Pediatr Endocrinol Rev. 2006;3:447\u201350.","journal-title":"Pediatr Endocrinol Rev"},{"key":"666_CR9","first-page":"650","volume":"37","author":"PW Speiser","year":"1985","unstructured":"Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet. 1985;37:650\u201367.","journal-title":"Am J Hum Genet"},{"key":"666_CR10","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1073\/pnas.83.9.2841","volume":"83","author":"Y Higashi","year":"1986","unstructured":"Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA. 1986;83:2841\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"666_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.709758","volume":"30","author":"C Carrozza","year":"2021","unstructured":"Carrozza C, Foca L, De Paolis E, Concolino P. Genes and pseudogenes: complexity of the RCCX locus and disease. Front Endocrinol. 2021;30: 709758.","journal-title":"Front Endocrinol"},{"key":"666_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40291-018-0319-y","volume":"22","author":"P Concolino","year":"2018","unstructured":"Concolino P, Costella A. Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency: a comprehensive focus on 233 pathogenic variants of CYP21A2 gene. Mol Diagn Ther. 2018;22:261\u201380.","journal-title":"Mol Diagn Ther"},{"key":"666_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40291-022-00588-0","volume":"26","author":"P Concolino","year":"2022","unstructured":"Concolino P, Falhammar H. CAH-X syndrome: genetic and clinical profile. Mol Diagn Ther. 2022;26:293\u2013300.","journal-title":"Mol Diagn Ther"},{"key":"666_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.788812","volume":"12","author":"M Kocova","year":"2022","unstructured":"Kocova M, Concolino P, Falhammar H. Characteristics of In2G variant in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Front Endocrinol. 2022;12: 788812.","journal-title":"Front Endocrinol"},{"key":"666_CR15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1056\/NEJMra021561","volume":"349","author":"PW Speiser","year":"2003","unstructured":"Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med. 2003;349:776\u201388.","journal-title":"N Engl J Med"},{"key":"666_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/cen.14190","volume":"93","author":"CS Fern\u00e1ndez","year":"2020","unstructured":"Fern\u00e1ndez CS, Taboas M, Bruque CD, Benavides-Mori B, Belli S, Stivel M, et al. Genetic characterization of a large cohort of Argentine 21-hydroxylase deficiency. Clin Endocrinol (Oxf). 2020;93:19\u201327.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"666_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1530\/EC-18-0281","volume":"8","author":"S Riedl","year":"2019","unstructured":"Riedl S, R\u00f6hl FW, Bonfig W, Br\u00e4mswig J, Richter-Unruh A, Fricke-Otto S, et al. Genotype\/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients. Endocr Connect. 2019;8:86\u201394.","journal-title":"Endocr Connect"},{"key":"666_CR18","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1210\/jc.2002-021681","volume":"88","author":"NM Stikkelbroeck","year":"2003","unstructured":"Stikkelbroeck NM, Hoefsloot LH, de Wijs IJ, Otten BJ, Hermus AR, Sistermans EA. CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. J Clin Endocrinol Metab. 2003;88:3852\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"666_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1515\/JPEM.1998.11.5.581","volume":"11","author":"A Wedell","year":"1998","unstructured":"Wedell A. An update on the molecular genetics of congenital adrenal hyperplasia: diagnostic and therapeutic aspects. J Pediatr Endocrinol Metab. 1998;11:581\u20139.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"666_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ymgme.2005.11.015","volume":"88","author":"A Fri\u00e3es","year":"2006","unstructured":"Fri\u00e3es A, R\u00eago AT, Arag\u00fc\u00e9s JM, Moura LF, Mirante A, Mascarenhas MR, et al. CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions. Mol Genet Metab. 2006;88:58\u201365.","journal-title":"Mol Genet Metab"},{"key":"666_CR21","first-page":"2845","volume":"86","author":"M Dracopoulou-Vabouli","year":"2001","unstructured":"Dracopoulou-Vabouli M, Maniati-Christidi M, Dacou-Voutetakis C. The spectrum of molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2001;86:2845\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"666_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1034\/j.1399-0004.2002.620213.x","volume":"62","author":"B Ezquieta","year":"2002","unstructured":"Ezquieta B, Cueva E, Oyarz\u00e1bal M, Oliver A, Varela JM, Jariego C. Gene conversion (655G splicing mutation) and the founder effect (Gln318Stop) contribute to the most frequent severe point mutations in congenital adrenal hyperplasia (21-hydroxylase deficiency) in the Spanish population. Clin Genet. 2002;62:181\u20138.","journal-title":"Clin Genet"},{"key":"666_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/humu.1380050205","volume":"5","author":"B Barbat","year":"1995","unstructured":"Barbat B, Bogyo A, Raux-Demay MC, Kuttenn F, Bou\u00e9 J, Simon-Bouy B, Serre JL, Mornet E. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency. Hum Mutat. 1995;5:126\u201330.","journal-title":"Hum Mutat"},{"key":"666_CR24","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1073\/pnas.1300057110","volume":"110","author":"MI New","year":"2013","unstructured":"New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, Chitayat D, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA. 2013;110:2611\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"666_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1530\/EJE-16-0171","volume":"175","author":"DF de Carvalho","year":"2016","unstructured":"de Carvalho DF, Miranda MC, Gomes LG, Madureira G, Marcondes JA, Billerbeck AE, et al. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction. Eur J Endocrinol. 2016;175:107\u201316.","journal-title":"Eur J Endocrinol"},{"key":"666_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1046\/j.1365-2265.2000.01048.x","volume":"53","author":"A Balsamo","year":"2000","unstructured":"Balsamo A, Cacciari E, Baldazzi L, Tartaglia L, Cassio A, Mantovani V, et al. CYP21 analysis and phenotype\/genotype relationship in the screened population of the Italian Emilia-Romagna region. Clin Endocrinol. 2000;53:117\u201325.","journal-title":"Clin Endocrinol"},{"key":"666_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/cge.13078","volume":"93","author":"A Gialluisi","year":"2018","unstructured":"Gialluisi A, Menab\u00f2 S, Baldazzi L, Casula L, Meloni A, Farci MC, et al. A genetic epidemiology study of congenital adrenal hyperplasia in Italy. Clin Genet. 2018;93:223\u20137.","journal-title":"Clin Genet"},{"key":"666_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1530\/EJE-11-0119","volume":"165","author":"L Ghizzoni","year":"2011","unstructured":"Ghizzoni L, Cappa M, Vottero A, Ubertini G, Carta D, Di Iorgi N, et al. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche. Eur J Endocrinol. 2011;165:307\u201314.","journal-title":"Eur J Endocrinol"},{"key":"666_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF03347422","volume":"30","author":"M Wasniewska","year":"2007","unstructured":"Wasniewska M, Di Pasquale G, Rulli I, Salzano G, Caruso M, Indovina S, et al. In Sicilian ethnic group non-classical congenital adrenal hyperplasia is frequently associated with a very mild genotype. J Endocrinol Invest. 2007;30:181\u20135.","journal-title":"J Endocrinol Invest"},{"key":"666_CR30","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1373\/clinchem.2003.028597","volume":"50","author":"HH Lee","year":"2004","unstructured":"Lee HH, Lee YJ, Chan P, Lin CY. Use of PCR-based amplification analysis as a substitute for the southern blot method for CYP21 deletion detection in congenital adrenal hyperplasia. Clin Chem. 2004;50:1074\u20136.","journal-title":"Clin Chem"},{"key":"666_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1172\/JCI115897","volume":"90","author":"PW Speiser","year":"1992","unstructured":"Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest. 1992;90:584\u201395.","journal-title":"J Clin Invest"},{"key":"666_CR32","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMra1909786","volume":"383","author":"DP Merke","year":"2020","unstructured":"Merke DP, Auchus RJ. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med. 2020;383:1248\u201361.","journal-title":"N Engl J Med"},{"key":"666_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1365-2265.2011.04123.x","volume":"75","author":"R Marino","year":"2011","unstructured":"Marino R, Ramirez P, Galeano J, Perez GN, Rocco C, Ciaccio M, et al. A. Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia. Clin Endocrinol. 2011;75:427\u201335.","journal-title":"Clin Endocrinol."},{"key":"666_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000497485","volume":"91","author":"R Santos-Silva","year":"2019","unstructured":"Santos-Silva R, Cardoso R, Lopes L, Fonseca M, Espada F, Sampaio L, et al. CYP21A2 gene pathogenic variants: a multicenter study on genotype-phenotype correlation from a Portuguese pediatric cohort. Horm Res Paediatr. 2019;91:33\u201345.","journal-title":"Horm Res Paediatr"},{"key":"666_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1515\/jpem-2017-0088","volume":"30","author":"\u015e Sava\u015f-Erdeve","year":"2017","unstructured":"Sava\u015f-Erdeve \u015e, \u00c7etinkaya S, Abal\u0131 ZY, Poyrazo\u011flu \u015e, Ba\u015f F, Berbero\u011flu M, et al. Clinical, biochemical and genetic features with nonclassical 21-hydroxylase deficiency and final height. J Pediatr Endocrinol Metab. 2017;30:759\u201366.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"666_CR36","doi-asserted-by":"publisher","first-page":"e2835","DOI":"10.1210\/clinem\/dgab280","volume":"106","author":"Q Lao","year":"2021","unstructured":"Lao Q, Merke DP. Letter to the Editor from Lao and Merke: \u201cEhlers-Danlos syndrome: molecular and clirnical characterization of TNXA\/TNXB chimeras in congenital adrenal hyperplasia.\u201d J Clin Endocrinol Metab. 2021;106:e2835\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"666_CR37","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.3390\/jcm11133818","volume":"11","author":"RM Paragliola","year":"2022","unstructured":"Paragliola RM, Perrucci A, Foca L, Urbani A, Concolino P. Prevalence of CAH-X syndrome in Italian patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. J Clin Med. 2022;11:3818.","journal-title":"J Clin Med"},{"key":"666_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jsbmb.2016.03.035","volume":"165","author":"KK Dumic","year":"2017","unstructured":"Dumic KK, Grubic Z, Yuen T, Wilson RC, Kusec V, Barisic I, et al. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia. J Steroid Biochem Mol Biol. 2017;165:51\u20136.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"666_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.671","volume":"7","author":"C Xu","year":"2019","unstructured":"Xu C, Jia W, Cheng X, Ying H, Chen J, Xu J, et al. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency. Mol Genet Genomic Med. 2019;7: e671.","journal-title":"Mol Genet Genomic Med"},{"key":"666_CR40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1210\/jcem.85.3.6441","volume":"85","author":"N Krone","year":"2000","unstructured":"Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab. 2000;85:1059\u201365.","journal-title":"J Clin Endocrinol Metab"},{"key":"666_CR41","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1210\/jc.2002-021433","volume":"88","author":"G Pinto","year":"2003","unstructured":"Pinto G, Tardy V, Trivin C, Thalassinos C, Lortat-Jacob S, Nihoul-F\u00e9k\u00e9t\u00e9 C, et al. Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management. J Clin Endocrinol Metab. 2003;88:2624\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"666_CR42","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","volume":"28","author":"S Baumgartner-Parzer","year":"2020","unstructured":"Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W. EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency. Eur J Hum Genet. 2020;28:1341\u201367.","journal-title":"Eur J Hum Genet"}],"container-title":["Molecular Diagnosis &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-023-00666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-023-00666-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-023-00666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T08:26:27Z","timestamp":1692260787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-023-00666-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["666"],"URL":"https:\/\/doi.org\/10.1007\/s40291-023-00666-x","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"assertion":[{"value":"12 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"PC, AP, CC, and AU have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Ethical review and approval were waived for this study, due to the diagnostic aim of the investigation. All procedures were performed in accordance with the ethical standards of the Ethics Committee of Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"PC and AP performed the diagnostic investigations and prepared manuscript. CC and AU writing\u2014review and editing. All authors have read and approved the final article.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}